Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SGI-1027

Inh 1020149-73-8 N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide
N° du produit ABIN7233289

Aperçu rapide pour SGI-1027 (ABIN7233289)

Application

Inhibition (Inh)

Chemical Name

N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide
  • Fonction

    DNA methyltransferase inhibitor

    Attributs du produit

    Potent and selective inhibitor of DNA methyl transferase inhibiting DNMT1, DNMT3A and DNMT3B with comparable potency (IC50=12.5, 8.0 and 7.5 956M respectively). Treatment of various cancer cell lines with SGI-1027 results in selective degradation of DNMT1 (MG-132 sensitive) with minimal effect on DNMT3A and 3B at 2.5-5 μM. Prolonged treatment of RKO cells resulted in reexpression of silenced tumor suppressor genes. Synergizes with doxorubicin at growth inhibition in neuroblastoma cell lines. Disrupts the MKK3-MYC complex in cells and inhibits MYC transcriptional activity in colon and breast cancer cells.

    Pureté

    >98 %

    Formula

    C27H23N7O

    Solubility

    Soluble in DMSO (35 mg/ml)
  • Restrictions

    For Research Use only
  • Format

    Powder

    Stock

    -20 °C
  • Sujet

    Epigenetics,Chromatin,DNA Methyltransferase,Prions,Cancer,Bcl,Myc

    Poids moléculaire

    461.5

    Numéro CAS

    1020149-73-8
Vous êtes ici:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!